GPCR

Conviction 27HealthcareScan · Thu, Jun 25, 2026

Shooting star

GPCR$48.29+0.26%

ResistanceSupportVol 14Insider sell

Vol MA14 968.95K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Structure Therapeutics Inc.PHARMACEUTICAL PREPARATIONSwww.structuretx.com ↗

Price48.29

Change+0.26%

Gap+0.44%

Rel volume0.98×

Avg volume850K

Avg $ vol36.11M

SMA 2041.96

SMA 5042.15

SMA 20048.74

Price vs 50+14.55%

Price vs 200-0.93%

MA stackmixed

50/200 cross—

Supertrendup · 42.15

RSI (14)71

MACD hist0.96

MACD cross—

Stoch %K / %D88 / 91

ADX (14)25

+DI / −DI35 / 12

RSI divergence—

MACD divergence—

ATR %+4.79%

ADR %5.15%

52w high93.79

52w low16.20

From 52w high-48.52%

Above 52w low+198.06%

New 52w highNo

SqueezeOff

Bollinger width32.69%

%B0.96

Donchian pos87.87%

Donchian high49.92

Donchian low36.45

AVWAP (52w high)61.10

vs AVWAP high-20.97%

AVWAP (52w low)48.42

vs AVWAP low-0.27%

OBV trendUp

Chaikin MF (20)0.11

Today vs 20d0.98×

Avg vol (14d)968.95K

Avg vol (20d)850K

Avg $ vol (20d)36.11M

Market cap10.3B

RS 3m (vs SPY)-9.88%

RS 6m (vs SPY)-33.58%

RS line new highNo

Trend template4/8

Technical rank51.4

1 week+7.30%

1 month+21.99%

3 months+0.32%

6 months-23.66%

1 year+115.75%

YTD-29.12%

P/E-72.91

P/B7.11

P/S—

P/FCF-45.59

EPS-0.8000

Div yield—

ROE-9.76%

ROA-9.36%

Debt/Eq—

Current26.16

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-15.24%

Price target110.17

Target upside128.17%

Analyst ratingBuy

Institutional31.92%

Ent. value9.98B

Revenue—

Net income-75.97M

Gross profit—

Free cash flow-225.81M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out71.07M

Employees233

ListedFri, Feb 3, 2023

Free float17.29M

Float %8.1%

Short interest5.57M

Days to cover9.0d

Short volume75.0%

Squeeze score85 / 100

Next earningsWed, Aug 5, 2026 (41d)

EPS forecast−$0.39 · 6 est

Last EPS vs est−$0.35 vs −$0.39

Last surprise+10.3% beat

Setup gradeD

Conviction27 / 100

Pattern quality—

Tech rank51.4 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmShooting star

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in GPCR

All disclosures →

No recent disclosed trades by Congress in GPCR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in GPCR · 8 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
LOVE TED W Director · Share Option (right to buy) · 2026-06-17	Grant	39.45K	—	2026-06-17	2026-06-18
WELCH DANIEL G Director · Share Option (right to buy) · 2026-06-17	Grant	39.45K	—	2026-06-17	2026-06-18
DOBMEIER ERIC Director · Share Option (right to buy) · 2026-06-17	Grant	39.45K	—	2026-06-17	2026-06-18
Russell Angus C. Director · Share Option (right to buy) · 2026-06-17	Grant	39.45K	—	2026-06-17	2026-06-18
TETLOW SHARON Director · Share Option (right to buy) · 2026-06-17	Grant	39.45K	—	2026-06-17	2026-06-18
Waldstreicher Joanne Director · Share Option (right to buy) · 2026-06-17	Grant	39.45K	—	2026-06-17	2026-06-18
Lang Matthew COO & GC · Share option (right to buy) · 2026-04-15	Grant	223.78K	$0	2026-04-15	2026-04-23
Lang Matthew COO & GC · Ordinary Shares · 2026-04-15	Grant	184.61K	$0	2026-04-15	2026-04-23
FMR LLC 10% owner · Ordinary Shares · 2026-04-14	Other	—	—	2026-04-14	2026-04-16
FMR LLC 10% owner · American Depositary Shares · 2026-04-14	Sell	16.09K	$886K	2026-04-14	2026-04-16

SEC filings

EDGAR filings in GPCR · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.